Physician profile
Maureen Muturi
NPI 1417549114
$4,965.41
in general payments reported to CMS, 2019-2025
16 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $1,394 · 2023: $2,135 · 2024: $844 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,041 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,040.84 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,104.09 | 2021-2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $610.49 | 2022-2025 | Austedo Xr, Uzedy, Austedo |
| Janssen Pharmaceuticals, INC | $598.12 | 2023-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $420.01 | 2021-2024 | Aristada, Lybalvi |
| Abbvie INC. | $412.03 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $408.00 | 2021-2024 | Rexulti, Abilify Maintena, Nuedexta |
| Sunovion Pharmaceuticals INC. | $404.98 | 2022 | |
| Vanda Pharmaceuticals INC. | $351.58 | 2022-2024 | Hetlioz, Fanapt |
| Lundbeck LLC | $195.25 | 2023-2024 | Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.85 | 2022-2024 | Caplyta |
| Indivior INC. | $145.25 | 2022-2024 | Perseris |
| Almatica Pharma LLC | $63.94 | 2022-2024 | Loreev Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $19.07 | 2021 | |
| Tris Pharma INC | $15.95 | 2024 | Dyanavel Xr |
| Emd Serono, INC. | $15.40 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Muturi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.